Alginate-Laminin Hydrogel Supports Long-Term Neuronal Activity in 3D Human Induced Pluripotent Stem Cell Derived Neuronal Networks

Significance 

Since the human brain is a three-dimensional structure, 3D culturing techniques can help researchers to create more accurate and realistic neural models, thus improving our understanding of the brain’s structure and function. Moreover, many neurological diseases are characterized by changes in the structure and connectivity of neurons. Creating a 3D neuronal network can be used to model a range of neurological disorders, including autism, epilepsy, and schizophrenia. This allows researchers to study disease mechanisms in a more physiologically relevant cellular context and improve the development of new treatments. Furthermore, a 3D neuronal network can be used to screen drug candidates for their efficacy and simultaneously identify neurotoxicity. This allows researchers to identify promising drug candidates early in the drug development process and avoid costly clinical trial failures.

However, developing a 3D neuronal network can be challenging, and there are several factors to consider. Some of the challenges include the choice of biomaterial since its properties highly influence the developing 3D neuronal network. To support neuronal growth and connectivity,  the materials should be biocompatible, must not elicit an immune response and must exhibit suitable mechanical properties such as stiffness and elasticity. The material should be porous, allowing for the diffusion of nutrients and waste products. Moreover, the material should be conductive to support the electrical activity of neurons.

Alginate is a natural polymer derived from seaweed that can form soft and porous gels when mixed with water and calcium ions. Laminin is a component of the extracellular matrix, which forms the scaffold that surrounds and supports cells in tissues. Laminin can bind to receptors on the surface of cells including human induced pluripotent stem cells (hiPSCs) and influence their behavior. In a new study published in the peer-reviewed Journal Advanced Materials Interfaces by PhD candidate Julia Hartmann, Dr. Ines Lauria, Ms Farina Bendt, Mr. Stephan Rütten, Dr. Katharina Koch and led by Professor Ellen Fritsche from Leibniz-Research Institute for Environmental Medicine in collaboration with Professor Andreas Blaeser at the Technical University of Darmstadt, the authors employed hiPSCs to generate human neural progenitor cells (NPCs) and subsequently let them differentiate into neural 3D models in both pure alginate hydrogels and hydrogels functionalized with the extracellular matrix protein laminin 111 (L111). The authors evaluated various properties of the tested biomaterials, such as their porosity, distribution of L111, shear viscosity, and biocompatibility. Additionally, the influence of the hydrogels on neural cell functions was studied by observing cell migration, differentiation, and the formation and activity of neural networks on multielectrode arrays (MEAs).

The research team used a 3D model of human NPCs derived from hiPSCs to study how the progenitors differentiate into functional neural networks. They found that L111 improved the survival, migration, and differentiation of NPCs into neurons and astrocytes, two key effector cell types in the brain that support each other. L111 also increased the formation of synapses, which are connections between neurons that allow them to transmit signals. They measured the electrical activity of these networks using MEAs and found that they were more mature, stable, and synchronized than those grown in alginate without L111. They also recovered faster from a drug that blocked their activity. The new 3D model established in the study provided a more physiological representation of human brain function than traditional 2D models and can be used for long-term disease models or studies of drug or chemical effects. Their work follows the 3R principles of reducing, refining, and replacing animal experiments with human-based methods.

In conclusion, Julia Hartmann and colleagues established a 3D model of hiPSC-derived neural networks embedded in alginate or alginate-laminin 111 (L111) hydrogels. They fully characterized the hydrogel’s material properties, cell compatibility, and effect on NPC differentiation and neural network formation over a long-term period of more than six months. Interestingly, L111 supplementation enhanced NPC-derived cell migration, differentiation, synaptogenesis, and electrical activity in alginate hydrogels. Moreover, neural networks in alginate-L111 hydrogel blends recovered faster from sodium channel blockage than neural networks in pure alginate hydrogels. In conclusion, alginate-L111 hydrogel is a suitable matrix for long-term cultivation and maturation of human neural networks. The new 3D neural cell model can be a powerful tool for medical research, allowing researchers to model diseases, study disease mechanisms, and develop new treatments.

About the author

Julia Hartmann is a Ph.D. candidate at the Leibniz Research Institute for Environmental Medicine (IUF) in Duesseldorf, Germany, in the research group of Prof. Fritsche. She received a Bachelor of Science in Bio- and Nanotechnologies from the South Westphalia University of Applied Sciences. The topic of her bachelor thesis was the investigation of the biocompatibility of silver halide materials using NIH-3T3 fibroblasts according to DIN EN ISO 10993-5 for biological assessment of medical devices. She obtained a Master of Science in Molecular Cell Biology from the University of Bielefeld. Her master thesis dealt with the material optimization for 3D bioprinting of hiPSC-based neural cells. During her Ph.D., she developed different hiPSC-based neural models by using diverse cultivation techniques such as monolayer (2D), suspension, and hydrogel culture and examined them concerning gene and protein expression, viability, electrical activity, and their suitability as new approach methods in neurotoxicity testing.

About the author

Ines Lauria (Ines Raschke), is a science manager at the German Aerospace Center (DLR, Deutsches Zentrum für Luft- und Raumfahrt e.V.). She received a Diploma in Molecular Biology and her PhD in Genetics from the University of Cologne. She was granted with a Diploma fellowship from the Faculty of Medicine (Koeln Fortune). During her early basic research PhD and postdoc studies in Cologne and at the Life and Medical Science Institute in Bonn she focused on the function and structure of membrane proteins within eukaryotic mitochondria and the plasma membrane employing Genetics, Biochemistry, Biophysics and Cell Biology imaging techniques. For the study on thrombin molecule activation she considered biomaterials for the first time – here nanosheets – for distinct imaging applications and therefore she got interested to work in applied science on Biomaterials. She started a position as a postdoc and lab manager at the RWTH Aachen University to develop modern Biomaterials including ceramics, metals and hydrogels as bone tissue replacements analyzed in interaction with human mesenchymal stem cells which she isolated from umbilical cord or bone marrow. Together with her collaborators she applied successfully for three project grants on novel Biomaterials also for bioprinting before she started the research on 3D in vitro neural tissues for neurotoxicological applications. For further details visit my LinkedIn or ResearchGate profile.

About the author

Katharina Koch holds a post-doc position at the Leibniz Research Institute for Environmental Medicine (IUF) in Duesseldorf, Germany. She received a B.S. degree in Biology and a M.Sc. degree in Molecular Biomedicine from the Rheinische Friedrich-Wilhelm University in Bonn. She received her PhD in biology from the Heinrich-Heine University of Duesseldorf for studying the metabolic dependencies of chemo- and radio-resistant tumor stem cells in malignant brain tumors for the discovery of novel tumor therapy targets. She was granted with a PhD fellowship from the Duesseldorf school of oncology (DSO). Her current research is part of the ENDpoiNTs project which received funding by the European Union’s Horizon 2020 research and innovation program. Here she focusses on the development of novel in vitro test methods for endocrine disruption (ED)-mediated developmental neurotoxicity (DNT) by studying how hormones and endocrine disrupting chemicals (EDCs) influence neurodevelopmental key events both in a species- and sex-specific manner. Therefore, she uses different multicellular human primary and iPSC-derived neural 3D models. She is involved in several validation management groups of PEPPER, a French public private platform for the pre-validation of endocrine test methods. She is a member of the German Society of Toxicology (DGPT) and a member of the editorial board of NeuroToxicology. Furthermore, she is a co-founder of the company DNTOX GmbH offering DNT assay development services and chemical testing for the chemical, cosmetic and pharmaceutical industry.

About the author

Prof. Dr.-Ing. Andreas Blaeser is head of the Institute for BioMedical Printing Technology at the Technical University of Darmstadt in Germany. Core of his research is the investigation of novel biofabrication processes (e.g. 3D-Bioprinting). Main focus areas are modelling and experimental research of various mechanisms and phenomena for the transport of biomaterials and their interaction with living cells. The research addresses major biofabrication challenges, such as the parallel printing of multifunctional material composites with different physical, chemical and biological properties. Furthermore, the pre- and post-processing steps accompanying the printing process, 3D data preparation and tissue maturation, are essential research elements. His work provides the basis for the future production of bioartificial tissues, “sentient” robotics and sustainable bioproducts. These can be used, for example, as implants in regenerative medicine, as sensor-integrated in vitro models for drug and toxicity studies, as artificial muscle in soft robotics, or in the field of cellular agriculture (e.g. cultured meat).

About the author

Ellen Fritsche, MD, is a full University Professor at the Heinrich-Heine-University in Düsseldorf, Germany and working group leader of the group ‘Alternative method development for environmental toxicity testing’ at the IUF – Leibniz Research Institute for Environmental Medicine. She is a medical doctor by training and habilitated in environmental toxicology. She has more than 20 years of experience in toxicological sciences including mechanistic studies and more than 15 years of experience in the development of new approach methods in vitro. She coordinated the European Food Safety Authority (EFSA)-developmental neurotoxicity (DNT) project for application of a DNT in vitro battery for regulatory purposes. She participates in the European projects, ENDpoiNTs, ONTOX and PARC. She is a member of the German MAK commission (Health Hazards of Chemical Compounds in the Work Area), the DNT in vitro OECD Expert Group and the scientific advisory group for the OECD DNT guidance document. She authored more than 90 publications in international peer-reviewed journals (h-index in Research Gate: 45), scientific opinions and book chapters. She is editor-in-chief of the journal Frontiers in Neurotoxicology. Recently, she founded the start-up company DNTOX – providing in vitro assay services for safety assessment. This paper was one of the achievements of an Innovation grant from Bayer in the context of CERST-NRW (Center for replacement of animal experiments in Northrhine Westfalia) that aimed at in vitro method development for substance testing without using animals.

Reference

Hartmann J, Lauria I, Bendt F, Rütten S, Koch K, Blaeser A, Fritsche E. AlginateLaminin Hydrogel Supports LongTerm Neuronal Activity in 3D Human Induced Pluripotent Stem CellDerived Neuronal Networks. Advanced Materials Interfaces. 2022 Dec 9:2200580.

Go To Advanced Materials Interfaces.

Check Also

Enhanced Multicolor Structured Illumination Microscopy via Dispersion-Compensated Digital Micromirror Devices